The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Dermoscopy Basic Algorithms

Systematic dermoscopic evaluation methodologies including pattern analysis (Pehamberger 1987 — first comprehensive method, identification of diagnostic patterns and structures), the ABCD rule of dermoscopy (Stolz, scoring asymmetry-border-color-differential structures), the 7-point checklist (Argenziano, simplified scoring with major and minor criteria), the CASH algorithm (color-architecture-symmetry-homogeneity), the 3-point checklist (asymmetry-atypical network-blue-white veil for screening), and Menzies method; essential decision-support tools for distinguishing benign nevi from melanoma (sensitivity 80-90 percent, specificity 60-90 percent — significantly improved over naked eye examination), with chaos and clues method as modern integrated approach; modern algorithms also include differentiation of pigmented (melanoma versus benign nevus) versus non-pigmented (basal cell carcinoma, squamous cell carcinoma versus benign), validated for hair, nail, and mucosal lesions; integration with reflectance confocal microscopy, digital dermoscopy with computerized AI-assisted analysis (MoleCheck, MoleMax, FotoFinder), and total body photography for comprehensive skin cancer screening programs.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Dermoscopy Basic Algorithms?

Dermoscopy basic algorithms are systematic evaluation methodologies developed for the standardized interpretation of dermoscopic (epiluminescence microscopy) images of pigmented and non-pigmented skin lesions. These algorithms provide structured frameworks for identifying specific dermoscopic features, calculating diagnostic scores, and reaching evidence-based decisions about lesion management including reassurance, monitoring, biopsy, or excision. The development of dermoscopic algorithms has revolutionized skin cancer screening by significantly improving diagnostic accuracy compared to naked-eye examination, with sensitivity for melanoma detection increasing from approximately 60 percent (naked eye) to 80-90 percent (dermoscopy) when used by trained clinicians.

History and evolution of dermoscopic algorithms: 1) Pattern analysis (Pehamberger, Steiner, and Wolff, 1987) — first comprehensive method developed at University of Vienna; based on identification of overall pattern, individual structures, and colors; remains gold standard for expert dermoscopists but requires extensive training; 2) ABCD rule of dermoscopy (Stolz, 1994) — modification of clinical ABCD criteria adapted for dermoscopic features with semi-quantitative scoring; designed for use by less experienced clinicians; 3) Menzies method (Menzies, 1996) — alternative scoring with negative and positive features; 4) 7-point checklist (Argenziano, 1998) — simplified algorithm with major (2 points) and minor (1 point) criteria; widely used in clinical practice; 5) CASH algorithm (Henning, 2007) — Color-Architecture-Symmetry-Homogeneity approach; 6) 3-point checklist (Soyer, Argenziano et al., 2004) — simplified screening tool with high sensitivity for melanoma detection by primary care physicians; 7) Modified pattern analysis approaches; 8) Chaos and clues method (Rosendahl, 2011) — designed for non-pigmented and pigmented lesions, integrating modern dermoscopic understanding; 9) BLINCK algorithm for non-pigmented lesions; 10) Recent algorithms integrating AI and digital analysis (commercial systems including FotoFinder Bodystudio, MoleMax, Vectra WB360 with AI-assisted analysis tools).

Pattern analysis (Pehamberger): foundational algorithm requiring identification of three main components: 1) Pattern — overall arrangement of structures within lesion (reticular pattern with regular pigment network typical of acquired nevi, globular pattern with brown globules typical of compound nevi, cobblestone pattern, homogeneous pattern with diffuse pigmentation typical of dermal nevi, parallel pattern on palms and soles — parallel furrow benign acral nevus versus parallel ridge melanoma, multicomponent pattern with three or more distinct components suspicious for melanoma, atypical pattern); 2) Specific structures — pigment network (regular fine reticular versus atypical irregular thickened lines), dots and globules (regular distribution versus atypical irregular), streaks (regular versus atypical), blue-white veil (irregular structureless blue area with overlying whitish ground-glass haze suggestive of melanoma), regression structures (white scar-like areas, peppering of gray-blue dots), vessels (point vessels, comma vessels, hairpin vessels, dotted vessels, glomerular vessels, polymorphous vessels), ulceration; 3) Colors — light brown, dark brown, black, blue-gray, white, red, yellow; presence of multiple colors (5-6) suspicious for melanoma.

ABCD rule of dermoscopy (Stolz): semi-quantitative scoring system based on four criteria: 1) Asymmetry (A) — assessed in two perpendicular axes; 0 points (symmetric in both axes), 1 point (asymmetric in one axis), 2 points (asymmetric in both axes); 2) Border (B) — assessment of abrupt cutoff at lesion edge in 8 segments; score 0-8 points (one point per segment with abrupt cutoff); 3) Color (C) — number of colors present from list of 6 (white, red, light brown, dark brown, blue-gray, black); 1-6 points; 4) Differential structures (D) — number of dermoscopic structures present from list of 5 (pigment network, structureless areas, branched streaks, dots, globules); 1-5 points; total dermoscopy score (TDS) = A × 1.3 + B × 0.1 + C × 0.5 + D × 0.5; interpretation: TDS < 4.75 benign, 4.76-5.45 suspicious, > 5.45 highly suspicious for melanoma; sensitivity 70-95 percent, specificity 70-95 percent depending on observer; advantages include reproducibility, semi-quantitative score; limitations include requiring training, may underdiagnose featureless melanomas.

Symptoms

Pigmented skin lesion requiring evaluation
New mole appearance
Changing mole (size, shape, color)
Multiple atypical nevi (dysplastic nevus syndrome)
Family history of melanoma
Multiple skin lesions for surveillance
Pigmented lesion in difficult location (scalp, palmoplantar, mucosal, nail)
Suspected basal cell carcinoma (pearly papule)
Suspected squamous cell carcinoma (scaly nodule)
Diagnostic uncertainty between benign nevus and melanoma
Patient with high melanoma risk requiring screening
Personal history of skin cancer
Patient request for skin cancer screening
Dermatology consultation for any pigmented lesion
Total body skin examination (TBSE) findings
Suspicious lesion on photographic surveillance
Pre-excision documentation of lesion
Equivocal clinical findings

Risk Factors

Multiple atypical nevi (dysplastic nevus syndrome)
Family history of melanoma (first-degree relative)
Personal history of melanoma
Family history of multiple atypical nevi
CDKN2A or BAP1 mutation carriers
Fair skin (Fitzpatrick I-II)
Red or blonde hair, blue eyes
History of significant sunburns
Excessive UV exposure (sun, tanning beds)
Immunosuppression (transplant recipients, HIV)
Multiple acquired nevi (>50)
Congenital nevus (especially large)
Xeroderma pigmentosum
Werner syndrome
Albinism
Previous skin cancer (any type)
Patient with limited dermoscopic training (need for algorithm support)
Time-pressured clinical setting requiring efficient decision-making

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Any new pigmented lesion appearing in adulthood
  • Existing mole changing in size, shape, color, symmetry, or borders
  • ABCDE warning signs (Asymmetry, Border irregularity, Color variation, Diameter > 6 mm, Evolution)
  • Bleeding or ulceration of mole
  • Itching or pain in mole
  • Mole that looks different from others (ugly duckling sign)
  • Family history of melanoma with new lesion
  • Personal history of skin cancer with new lesion
  • Multiple atypical nevi requiring surveillance
  • Pigmented lesion in difficult location (palmoplantar, mucosal, nail, scalp)
  • Suspicious lesion on routine skin examination
  • Patient request for total body skin examination
  • Inability to assess lesion adequately by clinical examination alone
  • Need for surveillance imaging documentation
  • Pre-operative dermoscopic mapping
  • Photoaged skin with multiple lesions
  • Annual skin cancer screening for high-risk patient

Treatment Methods

01
Initial assessment using dermoscopy: 1) Comprehensive patient history (skin type, sun exposure history, sunburns, prior skin cancer, family history of melanoma, immunosuppression, current medications, any changes noted by patient); 2) Total body skin examination (TBSE) with patient undressed and using good lighting; 3) Identification of all pigmented lesions and selection for dermoscopic evaluation (focus on changing, atypical, or symptomatic lesions, but examine all suspicious lesions); 4) Use of polarized or non-polarized dermoscope (handheld or attachment to digital camera, higher magnification 10x or 20x for detailed analysis); 5) Application of immersion fluid (alcohol gel, ultrasound gel) for non-polarized dermoscopy; 6) Systematic evaluation of each lesion using selected algorithm; 7) Photographic documentation of suspicious lesions
02
Application of pattern analysis: 1) First identify the dominant overall pattern (reticular, globular, cobblestone, homogeneous, parallel, multicomponent, structureless); 2) Identify specific structures present and characterize as regular versus irregular (pigment network — regular fine reticular versus atypical thickened irregular; dots and globules — regular peripheral or scattered versus irregular variable size and distribution; streaks — radial peripheral versus irregular; blue-white veil presence; regression areas; vascular structures); 3) Identify colors (light brown, dark brown, black, blue-gray, white, red, yellow); 4) Synthesize observations into diagnosis category (benign nevus, dysplastic nevus, melanoma, basal cell carcinoma, seborrheic keratosis, etc.); 5) Make management decision (reassurance, monitoring, biopsy, or excision)
03
Application of ABCD rule of dermoscopy: 1) Score each component systematically (A — asymmetry 0-2; B — border 0-8 segments with abrupt cutoff; C — colors present 1-6; D — differential structures 1-5); 2) Calculate TDS = A × 1.3 + B × 0.1 + C × 0.5 + D × 0.5; 3) Interpret: TDS < 4.75 benign, 4.76-5.45 suspicious (consider biopsy or close monitoring), > 5.45 highly suspicious (excisional biopsy indicated); 4) Caution: not validated for non-melanocytic lesions, special locations (acral, mucosal, facial), or amelanotic melanomas
04
Application of 7-point checklist: 1) Score major criteria (each 2 points) — atypical pigment network (irregular thickened branching lines), blue-white veil (irregular blue structureless area with overlying whitish), atypical vascular pattern (polymorphous vessels, dotted-globular vessels in melanoma); 2) Score minor criteria (each 1 point) — irregular streaks (radial unevenly distributed brown lines), irregular pigmentation (asymmetric distribution of pigment), irregular dots-globules (variable size and distribution), regression structures (white scar-like areas, peppering of gray-blue granules); 3) Sum score; >= 3 points suggests excisional biopsy for histopathologic evaluation; sensitivity 90 percent, specificity 70 percent for melanoma
05
Application of 3-point checklist (screening): 1) Asymmetry of color or structure (axes of symmetry); 2) Atypical pigment network (any irregular network); 3) Blue-white structures (any blue or white structureless area); score 2 or 3 of 3 suggests skin cancer requiring referral or biopsy; sensitivity 96.3 percent for melanoma; designed for use by primary care physicians and non-dermatologists; advantage in screening efficiency
06
Special pattern recognition for specific lesions: 1) Acral lesions (palms, soles) — parallel furrow pattern (benign), parallel ridge pattern (acral lentiginous melanoma), latticelike pattern, fibrillar pattern (benign), homogeneous pattern (benign in lighter pigmented patients, suspicious in darker pigmented patients); 2) Facial lesions — pseudonetwork (annular-granular pattern in lentigo maligna versus regular pseudonetwork in lentigo simplex), gray pseudonetwork, asymmetric pigmented follicular openings, rhomboidal structures, perifollicular gray dots; 3) Nail apparatus — longitudinal melanonychia evaluation (subungual hematoma versus subungual melanoma), regular versus irregular pigmentation, Hutchinson's sign extension to nail folds suggesting melanoma; 4) Mucosal lesions — pigmented mucosal lesions of lip, vulva, glans (different criteria than skin); 5) Basal cell carcinoma (BCC) — arborizing vessels (large branching telangiectasias), blue-gray ovoid nests, leaf-like areas, spoke-wheel structures, ulceration, pink shiny areas; 6) Squamous cell carcinoma (SCC) — keratin pearls, glomerular vessels (looped vessels), branching vessels, white circles around dilated vessels, dotted vessels, surface scale; 7) Seborrheic keratosis — milia-like cysts (white-yellow dots), comedo-like openings (dark dots, not associated with hair follicles), fissures and ridges (cerebriform pattern), fingerprint-like structures, sharp demarcation; 8) Hemangioma — red, purple, or red-blue lacunae (well-defined oval or round dark areas)
07
Differential dermoscopy by lesion type and location: 1) Common acquired nevi versus melanoma (pattern analysis, ABCD, 7-point checklist most useful); 2) Lentigo maligna — facial lesion specific criteria (gray pseudonetwork, asymmetric pigmented follicular openings, perifollicular gray dots, rhomboidal structures); 3) Pigmented basal cell carcinoma — distinguishing features include blue-gray ovoid nests, leaf-like areas, spoke-wheel structures (particularly diagnostic for BCC); 4) Hair-bearing scalp lesions — pseudoreticular pattern in nevi versus atypical features in melanoma; 5) Mucosal pigmentation — usually benign but requires evaluation; 6) Subungual lesions — careful evaluation for melanoma versus hematoma versus benign causes
08
Integration with digital dermoscopy and AI: 1) Digital dermoscopy systems with image storage for serial monitoring (MoleMax, FotoFinder, MoleCheck); 2) Total body photography (TBP) for surveillance of all lesions over time (Vectra WB360, ATBM); 3) AI-assisted analysis tools providing diagnostic suggestions and risk stratification (commercial systems including DermEngine, SkinVision, Skin Image Search); 4) Reflectance confocal microscopy (RCM) — quasi-histologic in vivo imaging at cellular resolution for ambiguous lesions; 5) Integration with electronic medical records for documentation and longitudinal tracking; 6) Mobile dermatology platforms for image consultation and remote dermoscopy review; 7) Educational resources including comprehensive dermoscopy atlases (online and apps), standardized training programs (ISDIS, IDS courses), competency assessment
09
Limitations and pitfalls: 1) Algorithms have lower sensitivity for amelanotic melanomas (require additional vascular pattern analysis); 2) Featureless or featureless melanoma may be missed by all algorithms; 3) Special site lesions (acral, mucosal, facial, nail) require modified criteria and specific algorithms; 4) Inter-observer variability significant especially for less experienced clinicians; 5) Spitz nevi can simulate melanoma dermoscopically (controversial — many recommend complete excision regardless); 6) Dysplastic nevi often score in suspicious range requiring careful clinical correlation; 7) Algorithm scoring should not replace clinical judgment; 8) Dermoscopic features may evolve over time (importance of digital monitoring); 9) Training and experience essential for accurate interpretation (60+ hour training recommended for proficiency)
10
Long-term outcomes and considerations: 1) Improved early melanoma detection with appropriate dermoscopic algorithm use; 2) Reduced unnecessary excision of benign lesions; 3) Better cost-effectiveness of skin cancer screening; 4) Standardized communication between clinicians; 5) Educational tool for residents and practicing physicians; 6) Patient confidence and reassurance with structured evaluation; 7) Continuous evolution with new evidence and AI integration; 8) International standardization through IDS (International Dermoscopy Society) and other organizations; 9) Future directions include enhanced AI assistance, automated lesion segmentation, deep learning algorithms with sensitivity matching expert dermatologists, and mobile teledermatology platforms

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.